On Success of One-Patient Study, TransDerm Aims to Advance siRNA Drug for Rare Skin Disorder

Additional clinical trials will likely use an experimental topical delivery vehicle after intradermal injections proved more painful to the patient than expected.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.